DiabetologyNews.net

Diabetology Xagena

Search results for "Hypoglycemia"

The FDA ( Food and Drug Administration ) approved Symlin, an injectable drug to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in ...


Exenatide ( Byetta ) reduced HbA1c with no weight gain and no increased incidence of hypoglycemia in patients with type 2 diabetes failing to achieve glycemic control with Metformin. Exenatide is t ...


FDA ( Food and Drug Administration ) has approved Exenatide ( Byetta ), also known as synthetic exendin-4, injection as adjunctive therapy to improve blood sugar control in patients with type 2 diabet ...


Results from a Phase III study indicated that Muraglitazar ( Pargluva ), an investigational compound, significantly decreased hemoglobin A1c ( HA1c ) levels at 24 weeks versus placebo in patients with ...


A temporary rise in blood glucose levels in people with both types of diabetes can interfere with their ability to think quickly and solve problems. The study has been published in Diabetes Care. ...


Clinical trials suggest that Rosiglitazone ( Avandia ), a drug that helps control blood glucose levels, may also reduce blood pressure in people with type 2 diabetes. According to the American Hear ...


A Phase III study showed Muraglitazar ( Pargluva ) 5 mg reduced A1C levels significantly more than Pioglitazone ( Actos ) 30 mg in patients with type 2 diabetes. Both treatment groups were taking M ...


Results from a study indicating that Exenatide ( Byetta ) injection showed sustained improvements in blood glucose control and progressive weight reduction through a year and a half of therapy for peo ...


Results from three Phase II studies showed that Sitagliptin ( Januvia ), an investigational medicine in a potentially new class of agents for the treatment for diabetes called DPP-IV ( dipeptidyl pep ...


Results from a study indicate that Exenatide injection ( Byetta ) improves blood glucose levels as effectively as Insulin Glargine ( Lantus ) for patients with type 2 diabetes failing to achieve accep ...


Results from three two-year studies showed that Exubera ( Human Insulin Powder ), an inhalable, short-acting, dry powder Insulin, provided effective, sustained glycemic control and was well tolerated ...


The study was designed to assess the safety, tolerability and pharmacokinetics of Exenatide ( Byetta ) LAR (long-acting release ) given once a week. After 15 weeks, both doses of Exenatide LAR were ...


Researchers reported that in a two-year, controlled study people with type 2 diabetes receiving Starlix ( Nateglinide ) in combination with Metformin experienced equivalent levels of overall blood glu ...


Intensive glucose control lowers the risk of heart disease and stroke by about 50 percent in people with type 1 diabetes. The findings, published in the New England Journal of Medicine. are based o ...


Phase III studies demonstrated that Sitagliptin ( Januvia ), an investigational oral, once-daily medicine for type 2 diabetes, significantly reduced blood glucose levels when used as monotherapy or as ...